DVADaVita

$179.29+38% 1Y

Is the business good?

Good

A genuinely good business: earnings fully cash-backed (1.3×) and margins widening.

2 good, 2 without data
Profits arrive as cash1.30×derived · Jun 30, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years+4.2 ptsderived

Negative operating leverage, costs are rising faster than sales, squeezing margins as it grows.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbetter than 87% of the market
Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is DVA?

DaVita earns 18% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

18%

Return on invested capital · cost of capital 9.0% · 9.0 points above what the capital costs: growth creates value

Operating margin
15%

Operating margin · Medical Care Facilities median 9.3% · 12 months to Q2 2026

Cash conversion
1.30×

Cash conversion · 1.12× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−15%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY202015%
FY202115%
FY202212%
FY202313%
FY202416%
FY202515%
Details›
Operating margin12 months to Q2 2026
15%
Net margin12 months to Q2 2026
6.0%
Free cash flow margin
11%
Revenue, trailing twelve months
$14.0B
Free cash flow, trailing twelve months
$1.61B
Net income, trailing twelve months
$847M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
18%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.